| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S1262-3636(07)70243-4 |
| P698 | PubMed publication ID | 16523183 |
| P2093 | author name string | Renard C | |
| Van Obberghen E | |||
| P2860 | cites work | The response-to-retention hypothesis of early atherogenesis | Q24629974 |
| Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation | Q24799326 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity | Q28364491 | ||
| Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet | Q28377461 | ||
| Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
| Leptin and the regulation of body weight in mammals | Q29615976 | ||
| Atherosclerosis. the road ahead | Q29618972 | ||
| Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice | Q32085363 | ||
| Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) | Q33764951 | ||
| Low density lipoprotein undergoes oxidative modification in vivo | Q33838672 | ||
| Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice | Q34142722 | ||
| Leptin promotes aggregation of human platelets via the long form of its receptor | Q77766009 | ||
| Effect of leptin on arterial thrombosis following vascular injury in mice | Q77855897 | ||
| Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol | Q78004667 | ||
| Defective central tolerance induction in NOD mice: genomics and genetics | Q81552095 | ||
| Imatinib attenuates diabetes-associated atherosclerosis | Q34301590 | ||
| Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice | Q34376178 | ||
| How does diabetes accelerate atherosclerotic plaque rupture and arterial occlusion? | Q35212858 | ||
| Antiatherogenic properties of metformin: the experimental evidence. | Q35539959 | ||
| Mechanism of lipoprotein retention by the extracellular matrix | Q35884626 | ||
| Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group | Q36244558 | ||
| Increased atherosclerosis in streptozotocin-induced diabetic mice | Q37353969 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. | Q38299150 | ||
| Inhibition of endogenous leptin protects mice from arterial and venous thrombosis. | Q38335888 | ||
| Leptin promotes vascular remodeling and neointimal growth in mice. | Q38348074 | ||
| Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis | Q38356091 | ||
| Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study | Q40788011 | ||
| Interleukin-6 exacerbates early atherosclerosis in mice | Q40793841 | ||
| Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts | Q41009444 | ||
| Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-ric | Q41664275 | ||
| Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels | Q43566166 | ||
| Diabetes-induced accelerated atherosclerosis in swine | Q43651836 | ||
| Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis | Q43687605 | ||
| Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response | Q43986613 | ||
| The total peroxyl radical trapping potential in serum - an assay to define the stage of atherosclerosis. | Q44029982 | ||
| Cholesteryl ester transfer protein expression prevents diet-induced atherosclerotic lesions in male db/db mice | Q44468915 | ||
| Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. | Q44552097 | ||
| Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity | Q44642265 | ||
| Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study | Q44895725 | ||
| Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. | Q44953934 | ||
| Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice | Q45120387 | ||
| Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. | Q45161321 | ||
| How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model | Q45783598 | ||
| Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice | Q45854348 | ||
| Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: a comparison of African and white Americans | Q46904300 | ||
| Marked reduction of pancreatic insulin content in male ventromedial hypothalamic-lesioned spontaneously non-insulin-dependent diabetic (Goto-Kakizaki) rats | Q48196514 | ||
| Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. | Q51555624 | ||
| The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. | Q51558704 | ||
| C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. | Q51570758 | ||
| Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse. | Q53856497 | ||
| Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall | Q68446303 | ||
| Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients | Q72050241 | ||
| Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow | Q72406593 | ||
| ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree | Q72689998 | ||
| Early morphologic changes of atherosclerosis induced by ventromedial hypothalamic lesion in the spontaneously diabetic Goto-Kakizaki rat | Q73031496 | ||
| Aortic atheromatous lesions developed in APA hamsters with streptozotocin induced diabetes: a new animal model for diabetic atherosclerosis. 1. Histopathological studies | Q73277904 | ||
| APA hamster model for diabetic atherosclerosis. 2. Analysis of lipids and lipoproteins | Q73277910 | ||
| Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys | Q77123248 | ||
| Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis | Q77124466 | ||
| Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients | Q77193505 | ||
| P433 | issue | 1 | |
| P921 | main subject | pathogenesis | Q372016 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 15-29 | |
| P577 | publication date | 2006-02-01 | |
| P1433 | published in | Diabetes and Metabolism | Q15758385 |
| P1476 | title | Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? | |
| P478 | volume | 32 |
| Q36885183 | AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPARγ |
| Q39784241 | Adipophilin affects the expression of TNF-alpha, MCP-1, and IL-6 in THP-1 macrophages |
| Q34591116 | Combination of Medicinal Herbs KIOM-79 Reduces Advanced Glycation End Product Accumulation and the Expression of Inflammatory Factors in the Aorta of Zucker Diabetic Fatty Rats |
| Q79291119 | Diabetic hepatosclerosis: a novel entity or a rare form of nonalcoholic fatty liver disease? |
| Q50096179 | Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage. |
| Q34399952 | Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice |
| Q45901856 | Effect of captopril and the bradykinin-PKC pathway on ROS production in type 1 diabetic rats. |
| Q36005335 | Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria |
| Q35111015 | High glucose-treated macrophages augment E-selectin expression in endothelial cells |
| Q46560187 | Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity |
| Q48677642 | Lidocaine metabolism in isolated perfused liver from streptozotocin-induced diabetic rats |
| Q35684097 | Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet |
| Q37012941 | Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E. |
| Q46858525 | Polyphenol isolated from Corni Fructus, 7-O-galloyl-D-sedoheptulose, modulates advanced glycation endproduct-related pathway in type 2 diabetic db/db mice |
| Q37415313 | Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase |
| Q38213250 | Role of free radical in atherosclerosis, diabetes and dyslipidaemia: larger-than-life. |
| Q42906142 | Short-term hyperglycaemia causes non-reversible changes in arterial gene expression in a fully ‘switchable’ in vivo mouse model of diabetes |
Search more.